Laura Cadden says Aastrom Biosciences, Inc. (NASDAQ:ASTM) is one of the hottest biotech stocks priced under $5. The company hopes to use its proprietary Tissue Repair Cell (TRC) technology to revolutionise treatment for heart disease. And it is making good progress through the trial phases. Laura says Aastrom is poised to make 20% gains in six months This from Today’s Financial News: Investors expect President-Elect Obama to make good on his campaign promise to lift restrictions on federally

November is just about over, and it was another month of honours, achievements, and attention-grabbing blog posts from Stem clients east to west. New Jersey criminal defense attorney John Marshall got a fun phone call the other day, from a writer/researcher from the popular Fox medical drama House! While we won’t go into detail here about what exactly the researcher was seeking an expert opinion on – you can read about at John’s New Jersey Criminal and DWI Defense Blog (feed) – this lends more

Are Americans simply too healthy to be sick than any other people in other countries in the world, or they simply have more access to a better health care system? If they are just too healthy, then why are there so many health insurance companies in the US, perhaps some of... read more

A lot of effort and study is going into improving healthcare and untangling its cost structure. So methinks it’s nearly criminal when someone blocks adoption of a treatment that’s better, especially when it’s also less expensive. Case in point, from yesterday’s NY Times: The Evidence Gap: The Minimal Impact of a Big Hypertension Study The surprising news made headlines in December 2002. Generic pills for high blood pressure, which had been in use since the 1950s and cost only pennies a day

Things You Need To Know About Renal Artery Stenosis Author: tk 28 Nov Renal artery stenosis is a condition in which your blood supply to your kidney is blocked. If you have this, your kidney will eventually become starved of oxygen and will eventually stop working. It causes between 5-22% of cases of advanced kidney disease in US patients over the age of 50. It may also be a factor in between 1-10% of adults with high blood pressure. The two major problems of renal artery stenosis is